2020-11-15T13:24:06-06:00 2020-06-30 410746749 CLIFTONLARSONALLEN LLP 1301 WEST 22ND STREET SUITE 1100 OAK BROOK IL 60523 990 2019-07-01 731386920 GATEWAY FOR CANCER RESEARCH GATE 8473427450 500 EAST REMINGTON ROAD SCHAUMBURG IL 60173 MICHAEL BURTON PRESIDENT 5473427450 2020-11-10 1 THOMAS G ANDREWS P00095596 6305738600 2020-11-10 67.137.57.251 2020-11-10 13:45:10 CS P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 F2512E052FD018023AA378234268090AB3D0521B 2019 2021-01-29 14:40:06Z MICHAEL BURTON 500 EAST REMINGTON ROAD SCHAUMBURG IL 60173 18584711 0 X GATEWAYCR.ORG X 1991 OK TO FIND AND FUND CLINICAL CANCER RESEARCH. 14 14 0 0 0 0 5180982 5112519 0 225000 400872 123313 0 0 5581854 5460832 3069665 5460236 0 0 0 0 0 0 0 100368 95202 3170033 5555438 2411821 -94606 15896617 17327076 9342263 10352659 6554354 6974417 X TO FUND MEANINGFUL AND BREAKTHROUGH CLINICAL TRIALS WORLDWIDE THAT HELP PEOPLE LIVING WITH CANCER TO FEEL BETTER, LIVE LONGER AND CONQUER CANCER TODAY! 0 0 5504321 5460236 225000 GATEWAY FOR CANCER RESEARCH (FORMERLY KNOWN AS CANCER TREATMENT RESEARCH FOUNDATION OR CTRF), A NON-PROFIT 501(C)(3) ORGANIZATION, WAS ESTABLISHED IN 1991 TO PROMOTE RESEARCH THAT MORE TRADITIONAL CANCER RESEARCH INSTITUTIONS MAY NOT FUND. GATEWAY IS DEDICATED TO ADVANCING INNOVATIONS IN THE SCIENTIFIC COMMUNITY AND SPEEDING THEM TO THE CANCER PATIENT'S BEDSIDE. THE WORK OF GATEWAY IS ABOUT GIVING CANCER PATIENTS THE ABILITY TO LIVE LONGER, MORE FULFILLING AND HEALTHIER LIVES.99% OF PUBLIC CONTRIBUTIONS RECEIVED ARE APPLIED DIRECTLY TO SUPPORT CANCER RESEARCH. OUR BOARD OF SCIENTIFIC COUNSELORS APPLIES STRINGENT GUIDELINES FOR REVIEWING EACH GRANT APPLICATION, RECOMMENDING TO THE BOARD OF DIRECTORS ONLY THOSE THAT ARE IN KEEPING WITH THE FOUNDATION'S MISSION. THROUGH THIS FORMAL REVIEW PROCESS, GATEWAY ENSURES THAT FUNDING IS GRANTED STRICTLY TO THOSE PROJECTS THAT ARE TRULY INNOVATIVE.AS THE NATION'S SECOND MOST DEADLY AND COSTLY DISEASE, CANCER RECOGNIZES NO BOUNDARIES. IN THE BATTLE AGAINST CANCER, GATEWAY IS ON THE FRONTLINES, SUPPORTING CLINICAL RESEARCH DESIGNED TO ENHANCE QUALITY OF LIFE FOR CANCER PATIENTS, SURVIVORS, AND FAMILIES. GATEWAY FOR CANCER RESEARCH HAS FUNDED OVER 233 STUDIES AND IS CURRENTLY FUNDING 56 STUDIES. 5504321 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 32 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 X 14 14 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 AZ CA CO CT FL IL ME MD MA MI MN MT MO NH NJ NY NC OH OK PA RI SC TN TX VA WA WI X X DIANE KINSLER 8473427450 500 EAST REMINGTON RD SCHAUMBURG IL 60173 X FRED DEGRANDIS SECRETARY 0.30 X X 0 0 0 JOE CALTABIANO DIRECTOR 0.30 X 0 0 0 DENIZ RAZON DIRECTOR 0.30 X 0 0 0 JAKE GOLDSTEIN DIRECTOR 0.30 X 0 0 0 RICHARD J STEPHENSON CHAIRMAN 0.30 X X 0 0 0 RHONDA KOKOT SECRETARY 0.30 X X 0 0 0 MARY LOU SMITH DIRECTOR 0.30 X 0 0 0 J TERRY SIMMONS DIRECTOR 0.30 X 0 0 0 KENNETH MONARREZ DIRECTOR 0.30 X 0 0 0 HEATHER KANE DIRECTOR 0.30 X 0 0 0 EDWIN ROBERSON DIRECTOR 0.30 X 0 0 0 CHRISTOPHER SURDENIK DIRECTOR 0.30 X 0 0 0 TONY FESTA TREASURER 0.30 X X 0 0 0 DAN GARMS DIRECTOR 0.30 X 0 0 0 STACIE J STEPHENSON VICE CHAIRMAN 0.30 X X 0 0 0 STEVEN DELCO DIRECTOR 0.30 X 0 0 0 CHRIS DOLEMAN DIRECTOR 0.30 X 0 0 0 MARGARET LAMANNA DIRECTOR 0.30 X 0 0 0 SATISH TADIKONDA DIRECTOR 0.30 X 0 0 0 AMY BELEW DIRECTOR 0.30 X 0 0 0 TIMMOTHY FLANIGAN ASST. SECRETARY 0.30 X X 0 0 0 TAWNYA BOND DIRECTOR 0.30 X 0 0 0 EMANUEL PETRICOIN PHD DIRECTOR 0.30 X 0 0 0 MICHAEL BURTON EX-OFFICIO, PRESIDENT 40.00 X 0 0 0 0 0 0 0 0 0 0 0 32991 3843691 1235837 5112519 GRANTS MANAGEMENT 541700 225000 225000 225000 386580 386580 12646705 12909972 -263267 -263267 -263267 213907 3843691 213907 0 5460832 225000 0 123313 5460236 5460236 27640 27640 BOARD OF SCIENTIFIC COU 44085 44085 BANK AND CREDIT CARD FE 23477 23477 5555438 5504321 51117 0 948765 3517920 2288253 2696033 1215647 45067 50000 46550 11143958 10874004 249994 147502 15896617 17327076 9339348 10214159 2915 138500 9342263 10352659 X 5351001 6910769 1203353 63648 6554354 6974417 15896617 17327076 X -94606 76656 438013 X X 0 1 X 1 0 X 3013245 5643089 3736215 5180982 5112519 22686050 3013245 5643089 3736215 5180982 5112519 22686050 3175147 19510903 433285 372615 461239 450046 386580 2103765 24789815 2215403 0.78710 0.82110 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X 10689170 76656 4527402 438013 213907 5255978 5433192 27640 27640 5460832 10269107 4527402 213907 4741309 5527798 27640 27640 5555438 PART X, LINE 2: THE FOUNDATION EVALUATES ITS EXPOSURE FOR UNCERTAIN TAX POSITIONS ON AN ANNUAL BASIS. AS OF JUNE 30, 2020 AND 2019, THERE WERE NO LIABILITIES RELATED TO UNCERTAIN TAX POSITIONS. PART XI, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSES NETTED WITH FUNDS GENERATED 213,907. PART XI, LINE 4B - OTHER ADJUSTMENTS: INVESTMENT MANAGEMENT FEES 27,640. PART XII, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSES NETTED WITH FUNDS GENERATED 213,907. PART XII, LINE 4B - OTHER ADJUSTMENTS: INVESTMENT MANAGEMENT FEES 27,640. SCHEDULE D, PARTS XII AND XIII, LINES 2D AMOUNTS REPRESENT DIRECT EXPENSES FOR SPECIAL EVENTS HELD AND ARE REFLECTED IN PART VIII ON LINE 8B AGAINST REVENUES FROM FUNDRAISING EVENTS. GALA 4057598 3843691 213907 213907 4057598 3843691 213907 213907 213907 0 1 CHILDREN'S HOSPITAL LOS ANGELES 4650 WEST SUNSET BOULEVARD MS 54 LOS ANGELES CA 90027 951690977 501(C)(3) 316667 CANCER RESEARCH MEMORIAL SLOAN-KETTERING CANCER CENTER 300 EAST 66TH STREET 8TH FLOOR NEW YORK NY 10065 131924236 501(C)(3) 510965 CANCER RESEARCH ST JUDE CHILDREN'S HOSPITAL 262 DANNY THOMAS PLACE MEMPHIS TN 38103 620646012 501(C)(3) 248000 CANCER RESEARCH MD ANDERSON CANCER CENTER 1515 HOLCOMBE BLVD HOUSTON TX 77030 174601118 501(C)(3) 446985 CANCER RESEARCH UNIVERSITY OF IOWA HOSPITALS AND CLINICS 200 HAWKINS DRIVE IOWA CITY IA 52242 426004813 501(C)(3) 239237 CANCER RESEARCH CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 3333 BURNET AVENUE CINCINNATI OH 45229 310833936 501(C)(3) 266666 CANCER RESEARCH CITY OF HOPE 1500 E DUARTE DUARTE CA 91010 951683875 501(C)(3) 411578 CANCER RESEARCH DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE BOSTON MA 02215 042263040 501(C)(3) 606981 CANCER RESEARCH BE THE MATCH FOUNDATION 500 N 5TH STREET MINNEAPOLIS MN 55401 411704734 501(C)(3) 266666 CANCER RESEARCH GEORGE MASON UNIVERSITY 4400 UNIVERSITY DRIVE FAIRFAX VA 22030 540836354 501(C)(3) 280696 CANCER RESEARCH UNIVERSITY OF ROCHESTER MEDICAL CENTER 601 ELMWOOD AVENUE BOX SURG ROCHESTER NY 14642 160743209 501(C)(3) 500000 CANCER RESEARCH MICHIGAN STATE UNIVERSITY 426 AUDITORIUM ROAD ROOM 2 EAST LANSING MI 48824 237326030 501(C)(3) 25000 CANCER RESEARCH DUKE UNIVERSITY DUMC 3085 05151A MORRIS BUILDING DURHAM NC 27710 560532129 501(C)(3) 236623 CANCER RESEARCH WAYNE STATE UNIVERSITY 4100 JOHN R MM05RA DETROIT MI 48201 386028429 501(C)(3) 259247 CANCER RESEARCH SEATTLE CHILDREN'S HOSPITAL 4800 SAND POINTE WAY SEATTLE WA 98105 911156519 501(C)(3) 844925 CANCER RESEARCH 15 0 PART I, LINE 2: ALL GRANT APPLICATIONS MUST GO THROUGH A RIGOROUS PEER REVIEW PROCESS LED BY OUR BOARD OF SCIENTIFIC COUNSELORS - A DISTINGUISHED BOARD OF RENOWNED SCIENTISTS, PHYSICIANS, RESEARCHERS AND PATIENTS. THROUGH THIS PROCESS, SCIENTISTS INCLUDING EXPERTS IN A PARTICULAR AREA OF CANCER REVIEW AND EVALUATE APPLICATIONS AGAINST A CAREFULLY PRESCRIBED SET OF CRITERIA FOR JUDGING THE SCIENTIFIC MERIT AND POTENTIAL VALUE OF EACH PROPOSED STUDY. THIS REVIEW, NOT ONLY INCLUDES A NUMERICAL GRADING OF OBJECTIVE CRITERIA, IT ALSO INCLUDES A SUBJECTIVE COMMENTARY WITH SUGGESTED MODIFICATIONS. UPON RECOMMENDATION BY THE BOARD OF SCIENTIFIC COUNSELORS, THE APPLICATION IS SUBMITTED TO GATEWAY'S BOARD OF DIRECTORS FOR FUNDING CONSIDERATION. IF APPROVED AND FUNDED, GATEWAY GRANTEES SUBMIT REGULAR REPORTS (I.E., SEMI-ANNUALLY) TO THE RESEARCH GRANTS DEPARTMENT THAT SUMMARIZE THE PROGRESS OF THE FUNDED TRIAL ACCORDING TO THE PRINCIPAL INVESTIGATOR'S PROPOSED TIMELINE AND MILESTONES. ANNUALLY, THE RESEARCH GRANTS TEAM REVIEWS ALL REPORTS SUBMITTED WITHIN THE PAST YEAR AND ASSESSES WHETHER GRANTS ARE "ON TRACK OR "OFF TRACK", WITH RESPECT TO PATIENT ACCRUALS, TIMELY REPORTING, AND PROGRESS TOWARD MEETING STUDY MILESTONES. WHEN NEEDED, THE RESEARCH GRANTS TEAM CONSULTS WITH THE BOARD OF SCIENTIFIC COUNSELORS TO REVIEW AND DEVELOP RECOMMENDATIONS FOR THE BOARD OF DIRECTORS ABOUT THOSE GRANTS THAT THEY DEEM "OFF TRACK". FUNDING CONTINUATION DECISIONS ARE CONTINGENT UPON GOOD PROGRESS/SPENDING. FORM 990, PART VI, SECTION A, LINE 2 BOARD MEMBERS RICHARD J STEPHENSON AND STACIE STEPHENSON ARE SPOUSES. BOARD MEMBERS RICHARD J STEPHENSON AND FRED DEGRANDIS ARE ALSO BOARD MEMBERS OF CANCER TREATMENT CENTERS OF AMERICA. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS FIRST REVIEWED BY THE ORGANIZATION'S INTERNAL STAFF AND A SUBSEQUENT REVIEW BY EXECUTIVE STAFF. THE FORM 990 IS THEN REVIEWED BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS AND SENT TO EACH CURRENT MEMBER OF THE BOARD FOR THEIR REVIEW AND ACTION. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION'S BOARD MEMBERS AND STAFF ARE REQUIRED TO REVIEW THE CONFLICT OF INTEREST POLICY DURING A REGULARLY SCHEDULED BOARD MEETING AND DURING THE STAFF MEMBERS ANNUAL PERFORMANCE EVALUATION MEETING. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC VIA WEBSITE AND OTHER NONPROFIT PUBLICATIONS. FORM 990, PART XI, LINE 9: RETURN OF UNUSED GRANT FUNDS 438,013. FORM 990, PART XII, LINE 2C THE ORGANIZATION'S BOARD OF DIRECTORS ASSUMES RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT. THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.